DNA polymerase III holoenzyme (referred to here as holoenzyme) is the 10-subunit replicative enzyme of Escherichia coli. Several biochemical properties distinguish this polymerase from the nonreplicative polymerases of E. coli. These include its requirement for single-stranded DNAbinding protein (15) , resistance to physiological concentrations of salt (2, 8, 17) and spermidine (11) , and very high processivity (52) . In addition, holoenzyme is thought to adopt an asymmetric, dimeric polymerase conformation that allows coordinated leading-and lagging-strand synthesis (19, 21, 33, 51) , and to interact with other proteins of the replisome (25) , e.g., the primosome (53, 56) , allowing additional communication among the various replication enzymes.
Holoenzyme can be divided into three functional components. The core polymerase, polymerase III (31) , contains three subunits: a (dnaE [50] ), the catalytic subunit (28, 29) ; E (dnaQ [9, 44] ), the 3'--5' proofreading subunit (9) ; and 0 (holE [4, 46] ), which has no known role. These three subunits are also isolable as part of a four-subunit complex, polymerase III' (30) , which contains the T subunit (dnaX [27, 35] ). Polymerase III is distinguished from holoenzyme by its sensitivity to single-stranded DNA-binding protein and spermidine (11) and by its very low processivity (11, 12) . Processivity is conferred on the polymerase by the 3 subunit (dnaN [3, 8] ), which assembles as a torus-shaped dimer around primed template DNA, forming a sliding clamp that fastens the polymerase to the template (23, 47) . The ,B subunit is loaded onto a primed template in a reaction requiring ATP hydrolysis and catalyzed by the y complex (23, 47) , a DNA-dependent ATPase containing ry (dnaX [13, 27] ), 8 (holA [5, 10] ), 8' (holB [5, 10] ), X (holC [6, 54] ), and P.
In in vitro replication reactions, the indispensable activity of the -y complex can be provided by the two-subunit complexes yb, Tb, and Tb' (36) . The contribution of the remaining two -y complex subunits, X and *, is more subtle. Together, X and * stabilize reconstituted polymerase (otel3yb) against higher concentrations of salt (36) and moderately stimulate the DNA-dependent ATPase activity of reconstituted y complex (-ybb' [37] ). To understand fully the * Corresponding author.
contribution of X and 4, to holoenzyme requires purification of large quantities of each subunit. In this report, we present a vital step toward this objective: the identification, isolation, and overexpression of the gene encoding 4.
MATERIALS AND METHODS Chemicals. Tris-HCl, polyvinylpyrrolidone, dextran sulfate, bovine serum albumin, and Ficoll were purchased from Sigma. Sodium dodecyl sulfate (SDS), acrylamide, N,N'-methylenebisacrylamide, ammonium persulfate, and Coomassie brilliant blue R-250 were purchased from Bio-Rad. Urea was purchased from Fisher. SeaKem LE agarose was purchased from FMC BioProducts.
Oligonucleotides. Oligonucleotides were synthesized at the University of Colorado Cancer Center Macromolecular Synthesis Core Facility and purified as described before (5) . Oligonucleotide sequences are shown in Fig. 1 (18) , was the source of E. coli chromosomal DNA. The primary cloning vector was pBlueScript II SK+ (Stratagene). All expression plasmids (pMAF51, pMAF300, pMAF310, and pRT581) were derivatives of pBBMD11, the original laboratory tac promoter-based expression plasmid (14, 32, 48) . pRT581 expresses the 51-kDa subunit of human immunodeficiency virus reverse transcriptase (48) . The X subunit expression plasmid pMAF51 (6) (7) .
DNA restriction fragments were separated by agarose gel electrophoresis, excised from the gel without UV irradiation of the DNA (7) , and purified with the GeneClean DNA purification kit from Bio 101.
Agarose gel electrophoresis. Horizontal agarose gel electrophoresis was performed as described before (42 (42) . Gels were dried and autoradiographed for 24 to 48 h with Kodak X-Omat AR X-ray film. Dideoxy chain termination sequencing of two independent isolates of the gene encoding 4 was performed by Lark Sequencing Technologies, Inc. (Houston, Tex.). The entire gene was sequenced in both directions.
PCR. PCR was performed in a Perkin Elmer Cetus model 480 PCR machine. Reactions designed to amplify fragments of the gene encoding 4 were performed with the Perkin Elmer GeneAmp PCR reagent kit that included AmpliTaq DNA polymerase. Each 100-,ul reaction mix contained 1 ng of E. coli chromosomal DNA and two oligonucleotide primers, each at 1 ,uM. Reaction mixes were incubated without polymerase or deoxynucleoside triphosphates (dNTPs) at 94°C for 7 min to denature template DNA and shifted to 85°C for 4 min to allow addition of polymerase and dNTPs. Reaction mixes were then cycled 35 times through a 1-min incubation at 94°C, a 5-min ramp from 50 to 65°C, and a rapid return to 94°C.
PCRs used to amplify the entire gene encoding 4 were performed with Vent polymerase and the reaction buffer supplied by New England Biolabs. Each 60-,ul reaction mix contained 100 ng of template DNA, two oligonucleotide primers, each at 1 ,uM, and bovine serum albumin at 100 ,ug/ml. Tubes containing template DNA and primers were incubated at 94°C for 7 min to denature the template and shifted to 85°C. One unit of Vent polymerase and the four dNTPs, each at a final concentration of 0.2 mM, were added to each reaction mixture. The reaction mixes were cycled 25 times through a 1-min incubation at 94°C, a 2-min incubation at 50°C, a 3-min incubation at 72°C, and a rapid return to 94°C. All PCR products were purified by agarose gel electrophoresis.
SDS-polyacrylamide gel electrophoresis. Holoenzyme subunits were separated by electrophoresis (26) in an SDS-7.5 to 17.5% polyacrylamide gel to obtain purified 4, subunit.
Protein from total cell lysates was separated on an SDS-12.5 to 20% polyacrylamide gel to analyze cells for overexpression of the 4 subunit. Gels were run in a Hoefer vertical gel electrophoresis apparatus for 16 h at 7 mA. Protein was visualized by staining with a 0.25% solution of Coomassie brilliant blue R-250 in 45% methanol and 10% acetic acid and destaining in a solution of 7.5% methanol and 10% acetic acid.
Overexpression of the * subunit. Overnight cultures were diluted 1:100 into 25 ml of fresh medium containing ampicillin. The 25-ml cultures were incubated at 37°C in a shaking waterbath. At an A6. of 0.5, 10 ml of each culture was induced by addition of IPTG (isopropylthiogalactopyranoside) to a final concentration of 1.0 mM, and growth of induced and noninduced cultures was continued for 5 h. Cells were pelleted by centrifugation, suspended in lysis buffer (100 mM Tris-HCl [pH 7 .5], 100 mM NaCl, 5% SDS, DNA and protein sequence analysis. GenBank DNA sequences were translated in all six reading frames with the TFASTA program and compared with the predicted sequence of * by the method of Pearson and Lipman (38) .
RESULTS
Cloning of the gene that encodes * required that we first obtain a DNA probe for the gene. To achieve this, we designed degenerate oligonucleotides based on peptide sequences of * and used these oligonucleotides in PCR to amplify a DNA fragment representing a portion of the gene. This fragment was used in hybridization experiments to map the gene, and the DNA sequence of the fragment was compared with sequences in GenBank to allow identification of the gene.
Peptide sequences of *. The 4 subunit was separated from purified holoenzyme by SDS-polyacrylamide gel electrophoresis, transferred onto a nitrocellulose membrane, and digested with trypsin. Tryptic fragments were separated by reversed-phase high-performance liquid chromatography (HPLC) (data not shown), and the amino-terminal sequences of three well-resolved peptides were determined, (1) (Fig. 2) To further analyze the PCR fragments, the 250-and 300-bp products were radiolabeled and hybridized to the Kohara miniset of chromosomal DNA clones. Both products hybridized to clones 672 and 673 (not shown), which both contain the DNA from kb coordinates 4634 to 4640 (about 99.2 centisomes) of the chromosome (22, 40) . That both PCR products hybridized to the same two chromosomal clones further indicated that these products originated from the same region of DNA.
Sequencing of the 300-bp fragment confirmed that the fragment represented an authentic portion of the gene encoding * (Fig. 3) . The sequence following primer 3.2 encoded nine consecutive amino acids located immediately after those residues used to design the primer. The sequence following primer 1 encoded the final amino acid of peptide 1, which was not used to design the primer (Fig. 3B) . In addition, the 300-bp fragment contained DNA that encoded all of peptide 2 (with the exception of the two ambiguous residues of this peptide). In total, the 300-bp fragment contained sequence encoding 19 experimentally derived amino acid residues that were not used in design of the PCR primers used to amplify the fragment.
Mapping the gene encoding *. Chromosomal DNA, digested with a battery of restriction enzymes, was analyzed by Southern hybridization with the 300-bp fragment as a gene-specific probe. A single restriction fragment was identified for each digestion, indicating a single locus complementary to the probe. Data from the Southern blot (not shown) were used to construct a restriction map of the region of the chromosome complementary to the probe (Fig.  4) . This restriction map aligned with the 99-min region of the E. coli chromosomal restriction map (22) hybridized to the 300-bp probe. The gene was mapped more precisely to 99.3 centisomes by comparing the restriction map shown in Fig. 4 with the most recent map of the E. coli chromosome, which correlates the physical and genetic maps (40, 41) .
Cloning and sequencing the gene encoding *. (55) (Fig. 5) . The 5' end of the open reading frame except for two base changes that created preferred codons synonymous with the poorly used codons found in the wild-type sequence (24) and contained a consensus ribosome-binding site (39) separated from the ATG initiation codon by 9 bp. Both primers also contained restriction endonuclease recognition sites to aid in cloning of the PCR fragment. The modified open reading frame predicted to encode 4 was inserted downstream of the strong tac promoter of pRT581 (Fig. 6A) to create pMAF300. Sequence -35 -10 SD begin j gene analysis of the open reading frame in pMAF300 indicated that no base changes had occurred during PCR. However, when tested in several strains and under several induction conditions, pMAF300 failed to promote overexpression of 4 (data not shown). At least two possibilities might explain this result: (i) the 4 subunit is very labile, or (ii) translation is inefficient despite the modifications designed to enhance expression. To circumvent the latter problem, we moved the open reading frame into a plasmid that directs high-level expression of holC, the gene encoding the X subunit of holoenzyme (6, 54) , to create pMAF310 (Fig. 6A) . The peptide containing the amino-terminal nine residues of valS fused to three additional residues (Fig. 6B) . (valS is immediately downstream of hoiC. Sequence analysis indicates that valS is probably translationally coupled to holC [6] .) The critical component of the coupling was the placement of the termination codon for the 12-residue peptide immediately after a consensus ribosome-binding site and six bases before the initiation codon of the 4 open reading frame. Translational reinitiation of a downstream gene typically approaches 100% when the upstream gene terminates between a ribosome-binding site and an initiation codon (16) .
Plasmid pMAF310 was introduced into MC1061 to create MAF310, and this strain was tested for the ability to produce X and 4, after IPTG induction (Fig. 7) . Also included in this induction experiment were MAF151, containing the hoiC overexpression plasmid pMAF51, and MC1061 with no plasmid. MC1061 overproduces neither subunit when induced with IPTG (Fig. 7, compare lanes 1 and 2) . MAF151 overproduces the X subunit when induced with IPTG (Fig. 7,  compare lanes 3 and 4) , as reported previously (6) . MAF310 overproduces two proteins that comigrate with the X subunit and the 4, subunit of purified holoenzyme when induced with IPTG (Fig. 7, compare lanes 5 and 6) . Densitometric analysis of lanes 5 and 6 of Fig. 7 Given the apparent lack of a correctly positioned ribosomebinding site upstream ofnimI, it is possible that translation of nimI mRNA is at least partially coupled to expression of 4. However, the 29 bp between the nmI initiation codon and the holD termination codon is longer than the usual distance of not more than 10 bases (16) required for translational coupling. Moreover, a protein of the molecular mass of was not detected in maxicells that expressed RimI from a plasmid containing both holD and nimI (55) .
We observed similar results with a plasmid designed to overproduce 4. Regardless of the strain or the induction conditions used, we were not able to detect expression of by SDS-polyacrylamide gel electrophoresis. However, when coexpressed from a plasmid that also produces the X subunit of holoenzyme, was produced to about 3% of total soluble protein. Since X and are components of the y complex (,y, 8, 8', X, and 4) and have activity in vitro, it is possible that X and form a complex in which becomes resistant to proteolytic degradation or which is more soluble than when the subunit is expressed alone at high levels. Alternatively, the high level of expression from cells containing the plasmid with holC and holD could be due to efficient translation initiation of holD through translational coupling of hoiC to a valS peptide and of the valS peptide to holD. However, Heck and Hatfield (20) have shown that valS is expressed from two promoters about 100 bp upstream of its initiation codon, i.e., within hoiC. Thus, valS expression is at least partially independent of holC expression.
The structural and functional contribution of to holoenzyme is poorly understood. However, having successfully isolated and overexpressed holD, we are now in a position to purify large quantities of the protein and to determine the interactions of the subunit with X, with the remainder of the y complex, and with the remaining complement of holoenzyme subunits.
